ClinicalTrials.gg
RecruitingNCT06065709Updated Mar 13, 2024

Mindfulness Breath Awareness Meditation and Preeclampsia

An interventional study of Mindfulness breath awareness meditation in Mindfulness Breath Awareness Meditation and Preeclampsia, sponsored by Aysegul Kilicli. Recruiting at 1 site in Turkey. Open to female participants aged 19 Years to 49 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-03-13.

Sponsored by Aysegul Kilicli · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Primary completion was expected by Apr 2024, 2 years 7 months ago, but the record still lists the study as recruiting.
  • Started Oct 2023; still recruiting 3 years 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
66
Allocation
Randomized
Ages
19 Years to 49 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 50 studies in Pre-Eclampsia with a site in Turkey — 11 open to participants now, 11 under way, none of them phase 3. Pre-Eclampsia · Turkey.

Planned enrollment
14th of 19
66 · median 84
Started
2023
with 7 others
No phase
17 of 50
5 open now
Primary completion
2024-04
later than 0 of 10 live
Registered
28th of 50
by date

Among the 50 studies in Pre-Eclampsia with a site in Turkey, this one is the 14th largest by planned enrollment of the 19 interventional ones that give a count, is one of 8 that started in 2023, is one of 17 with no phase, reaches primary completion later than 0 of the 10 other live ones, and was the 28th registered.

Pre-Eclampsia

918 studies on the registry are indexed under Pre-Eclampsia; 243 are open to participants now.

Browse Pre-Eclampsia studies →

Open to participants now

11 of the 50 studies in Pre-Eclampsia with a site in Turkey are open now. Recruiting first, the newest first:

5 more — sign in →

All 11 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 160 Pre-Eclampsia studies recruiting now, 79 (49%) set no upper age limit and 80 (50%) stop at 75 or younger; 18 take children under 18; 59 take healthy volunteers.

This study: 19 Years to 49 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 50 studies in Pre-Eclampsia with a site in Turkey, or all of them as a file.
02

Study summary

The effect of mindfulness breath awareness meditation on health profile, vital signs, and fetal heart rate in pregnant women with preeclampsia

Read the detailed description

The aim of this study is to determine the effect of mindfulness breath awareness meditation (MBAM) on health profile, vital signs, and fetal heart rate in pregnant women with preeclampsia.

Sample size:

  • There will be two groups in the study.
  • Experiment group is breath awareness meditation group.
  • The sample size of the study is 66 women.
  • The sample size will be divided into two and 33 women will be randomly assigned to each group.

Application time:

  • The application will be started after the pregnant women diagnosed with pre-eclampsia is admitted to the Perinatology service.
  • It will be applied total nine times in once every eight hours during the 72 hours that the pregnant women diagnosed with 20 minutes.
  • Only mindfulness breath awareness meditation (MBAM) will not be applied to the control group. Care and follow-up will be performed in parallel with the individuals in the experimental group.

Data Collection Tools:

  • Descriptive Information Form
  • Nottingham Health Profile Scale

Measurement time:

  • Pregnant women will fill in the Introductory Information Form before the first application.
  • Each session of mindfulness breath awareness meditation practice will 20 minutes.
  • Pregnant women will fill the Nottingham Health Profile Scale before the first application. It will then be refilled at the same time every 24 hours for 72 hours. The Nottingham Health Profile will be completed a total of four times.
  • Vital signs (systolic and diastolic blood pressure, body temperature, pulse, respiration, oxygen saturation) will be measured immediately before the first application. They will then be refilled at the same time every 24 hours for 72 hours. Vital signs will be completed a total of four times.
  • Fetal heart rate and fetal movement count will be measured immediately before the first application. They will then be refilled at the same time every 24 hours for 72 hours. Fetal heart rate and fetal movement count will be assessed by Non-stress Testing (NST). The pregnant woman will undergo NST for 20 minutes.
03

Conditions studied

  • Mindfulness Breath Awareness Meditation
  • Preeclampsia

Browse trials for

Keywords

  • Mindfulness breath awareness meditation
  • Preeclampsia
  • Pregnant women
  • Health profile
  • Vital signs
  • Fetal heart rate
04

Who can participate

Ages eligible
19 Years to 49 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • pregnant women who is admitted to the Perinatology Service of the hospital with the diagnosis of preeclampsia,
  • who is 19 to 49 years old,
  • who is 20 and over weeks of gestation,
  • who followes by at least three days of hospitalization in the ward.

Exclusion criteria

Exclusion Criteria:

  • Pregnant women who do not meet the inclusion criteria and who voluntarily withdraw at any stage after inclusion will be excluded from the study.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
66 participants (estimated)

Study arms

  • Experimental
    Mindfulness breath awareness meditation group

    Mindfulness breath awareness meditation will be performed nine times in total, once every eight hours within 72 hours, to the pregnant woman who is hospitalised in the perinatology service of the hospital with the diagnosis of preeclampsia. Each session will last 30 minutes. A 4-stage mindfulness breath awareness meditation includes the following stages: Stage 1 - Body Harmony. Stage 2 - Counting as you Exhale Stage 3 - Counting while Breathing Stage 4 - Sit Still and Witness.

    Behavioral: Mindfulness breath awareness meditation

  • No intervention
    control group

    only mindfulness breath awareness meditation will not be applied to the control group.

Interventions

  • BehavioralMindfulness breath awareness meditation

    Mindfulness breath awareness meditation

06

What researchers measure

Primary outcomes

  1. Nottingham Health Profile

    Nottingham Health Profile The scale consists of 38 questions and 6 sub-dimensions. The scale consists of 8 questions on physical activity (PA), 8 questions on pain (P), 5 questions on sleep (S), 3 questions on energy level (EL), 9 questions on emotional reactions (ER), 5 questions on social isolation (SI). Questions are answered as 'yes' or 'no', item score calculations in each sub-dimension differ, the best score that can be obtained from each sub-dimension is '0' and the worst score is '100'. The minimum score that can be obtained from the whole scale is 0 and the maximum score is 600. Quality of life improves as the score decreases.

    Time frame: It will be evaluated before the first application and then every 24 hours for a total of 4 times

  2. Fetal heart rate

    Fetal heart rate

    Time frame: It will be evaluated before the first application and then every 24 hours for a total of 4 times

  3. Body temperature

    Body temperature

    Time frame: It will be evaluated before the first application and then every 24 hours for a total of 4 times

  4. Pulse

    Pulse

    Time frame: It will be evaluated before the first application and then every 24 hours for a total of 4 times

  5. Systolic blood pressure

    Systolic blood pressure

    Time frame: It will be evaluated before the first application and then every 24 hours for a total of 4 times

  6. Diastolic blood pressure

    Diastolic blood pressure

    Time frame: It will be evaluated before the first application and then every 24 hours for a total of 4 times

  7. Respiratory rate

    Respiratory rate

    Time frame: It will be evaluated before the first application and then every 24 hours for a total of 4 times

  8. Oxygen saturation

    Oxygen saturation

    Time frame: It will be evaluated before the first application and then every 24 hours for a total of 4 times

Secondary outcomes

  1. fetal movement count

    fetal movement count

    Time frame: It will be evaluated before the first application and then every 24 hours for a total of 4 times

  2. Nottingham Health Profile subdimensions

    Nottingham Health Profile subdimensions physical activity, pain, sleep, energy, emotional reactions, and social isolation

    Time frame: It will be evaluated before the first application and then every 24 hours for a total of 4 times

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2023 (actual). Primary completion is estimated for Apr 2024, 6 months after the start.

Of 172 non-industry interventional studies with no phase under Pre-Eclampsia, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 6 months is below that.

Counting every sponsor, half of 177 studies reached it within 24 months; a quarter within 10 and three quarters within 44.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 19, 2023
First posted
Oct 4, 2023
StartActual
Oct 1, 2023
Primary completionEst.
Apr 1, 2024
CompletionEst.
Apr 1, 2024
Last update
Mar 13, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 13, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06065709
Lead sponsor
Aysegul Kilicli
Responsible party
Aysegul Kilicli (gaziantep university health sciences enstitute nursing department PhD, University of Gaziantep) — Sponsor-investigator
First posted
Oct 4, 2023
Start date
Oct 1, 2023
Primary completion
Apr 1, 2024 (estimated)
Completion
Apr 1, 2024 (estimated)
Last update
Mar 13, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion